Healthcare resource burden associated with hyponatremia among patients hospitalized for heart failure in the US

Journal of Medical Economics

Volumn 16, Issue 3, 2013, Pages 415-420

  Amin, Alpesh ^a   Deitelzweig, Steven ^b   Christian, Rudell ^c   Friend, Keith ^c   Lin, Jay ^d   Lowe, Timothy J ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^d Novosys Health   (United States)

^e Premier Inc   (United States)

Author keywords

Healthcare costs; Healthcare utilization; Heart failure; Hyponatremia; Readmission

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CLINICAL PRACTICE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL COST; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; HYPONATREMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SCORING SYSTEM; UNITED STATES; UTILIZATION REVIEW;

AGED; COST OF ILLNESS; FEMALE; HEALTH RESOURCES; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPONATREMIA; MALE; NORTH CAROLINA; PATIENT READMISSION; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84873935523     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2013.766615     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention. Heart failure fact sheet. http://www.cdc.gov/DHDSP/data-statistics/fact-sheets/fs-heart-failure.htm. Accessed April 9, 2012
2. Chen MC, Chang HW, Cheng CI, et al. Risk stratification of in-hospital mortality in patients hospitalized for chronic congestive heart failure secondary to non-ischemic cardiomyopathy. Cardiology 2003;100:136-42
3. Gheorghiade M, Rossi JS, Cotts W, et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med 2007;167:1998-2005
4. Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007;28:980-8
5. Romanovsky A, Bagshaw S, Rosner MH. Hyponatremia and congestive heart failure: a marker of increased mortality and a target for therapy. Intern J Nephrol 2011;2011:732-46
6. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73:257-67
7. Shorr AF, Tabak YP, Johannes RS, et al. Burden of sodium abnormalities in patients hospitalized for heart failure. Cong Heart Fail 2011;17:1-7
8. Boscoe A, Paramore C, Verbalis JG. Cost of illness of hyponatremia in the United States. Cost Eff Resour Alloc 2006;4:1-11
9. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9
10. Nixon RM, Thompson SG. Parametric modeling of cost data in medical studies. Statist Med 2004;23:1311-31
11. Wald R, Jaber BL, Price LL, et al. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 2010;170:294-302
12. Zilberberg MD, Exuzides A, Spalding J, et al. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin 2008;24:1601-8
13. Callahan MA, Do HT, Caplan DW, et al. Economic impact of hyponatremia in hospitalized patients: a retrospective cohort study. Postgrad Med 2009;121:186-91
14. Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007;28:980-8
15. Dunlay SM, Gheorghiade M, Reid KJ, et al. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail 2010;12:367-74
16. Stranges E, Stocks C. Potentially preventable hospitalizations for acute and chronic conditions, 2008. HCUP Statistical Brief #99. Rockville, MD: Agency for Healthcare Research and Quality, 2010. http://www.hcup-us.ahrq.gov/reports/ statbriefs/sb99.jsp. Accessed April 10, 2012
17. Stone J, Hoffman, GJ. Medicare hospital readmissions: issues, policy options and PPACA. (R40972). Washington, DC: Congressional Research Service, 2010. http://www.hospitalmedicine.org/AM/pdf/advocacy/CRS- Readmissions-Report. pdf. Accessed May 5, 2012
18. Chiong JR, Kim S, Lin J, et al. Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hypona-tremia in the US, based on the EVEREST trial. J Med Econ 2012;15:276-84